# Quality Score Report: ADR-001 NPT-014 Elimination Policy (I4)

## L0 Executive Summary

**Score:** 0.9520/1.00 | **Verdict:** PASS | **Weakest Dimension:** Completeness (0.96, all others 0.95)
**One-line assessment:** ADR-001 I4 applies the single-edit fix that I3 introduced as a regression -- "6" corrected to "5" at line 277 -- restoring Internal Consistency from 0.92 to 0.95 and lifting Actionability from 0.94 to 0.95, producing a composite of 0.9520 that clears the C4 threshold of 0.95 by 0.0020.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/phase-5/ADR-001-npt014-elimination.md`
- **Deliverable Type:** ADR (Architecture Decision Record)
- **Criticality Level:** C4
- **C4 Threshold:** 0.95 (elevated from standard H-13 threshold of 0.92)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **ADR Gate Checks Applied:** GC-ADR-1 through GC-ADR-5, A-11 check, AGREE-5 check
- **Strategy Findings Incorporated:** Yes -- I3 report (adversary-adr001-i3.md, score 0.9445 REVISE) incorporated as prior context
- **Prior Scores:** I1: 0.9185, I2: 0.9455, I3: 0.9445
- **Iteration:** I4 (fourth scoring)
- **Scored:** 2026-02-28T00:00:00Z

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.9520 |
| **C4 Threshold** | 0.95 |
| **Standard H-13 Threshold** | 0.92 |
| **Verdict** | PASS |
| **Distance from C4 Threshold** | +0.0020 (above) |
| **I3 Score** | 0.9445 |
| **Score Delta (I3 -> I4)** | +0.0075 |
| **Score Trajectory** | I1: 0.9185 -> I2: 0.9455 (+0.0270) -> I3: 0.9445 (-0.0010) -> I4: 0.9520 (+0.0075) |
| **Strategy Findings Incorporated** | Yes (I3 report) |
| **FMEA Arithmetic Verified** | YES -- all 5 RPN values correct (72, 48, 100, 150, 28) |
| **L2 Token Budget Arithmetic Verified** | YES -- 745/850 = 87.6%, within ceiling |

---

## Gate Check Results

| Gate | Description | Status | Evidence |
|------|-------------|--------|----------|
| GC-ADR-1 | Nygard format compliance (Title, Status, Context, Decision, Consequences) | PASS | All 5 required sections present; extended with L0/L1/L2, Forces, Options, Compliance |
| GC-ADR-2 | Evidence tier labels on ALL claims | PASS | A-31 fully cited with arXiv:2312.16171 (I3); A-20/A-15 fully cited with arXiv URLs (I2); VS-001/VS-003 disambiguated (I3); all 8 Evidence Base table entries carry tier labels |
| GC-ADR-3 | PG-003 reversibility assessment present | PASS | Full 5-component reversibility table; HIGH overall; null-framing contingency documented |
| GC-ADR-4 | Phase 2 dependency correctly handled | PASS | Unconditional exception explicitly stated; "Phase 2 outcome irrelevant" sourced to barrier-4/synthesis.md Section 3 |
| GC-ADR-5 | No false validation claims | PASS | MANDATORY EPISTEMOLOGICAL BOUNDARY enforced; UNTESTED label applied to NPT-009 vs. positive framing; A-11 absent throughout |
| A-11 check | A-11 (hallucinated citation) absent | PASS | Zero occurrences as evidence citation; appears only in constraint prohibition roles (lines 107, 541, 557) |
| AGREE-5 check | AGREE-5 not presented as T1/T3 | PASS | Line 64: labeled "internally generated, NOT externally validated"; not cited as peer-reviewed evidence anywhere |

---

## I4 Fix Verification

| I3 Fix Target | Applied in I4? | Evidence | Score Impact |
|---------------|---------------|----------|--------------|
| "6" -> "5" at line 277 (count corrected to match 5-row sub-table) | YES | Line 277 reads: "TASK-012 identified **5** specific upgrade recommendations (R-QE-001 through R-ADS-003)" -- numeral matches sub-table row count (R-QE-001, R-QE-002, R-ADS-001, R-ADS-002, R-ADS-003 = 5 rows) | Internal Consistency: 0.92 -> 0.95 (+0.03 x 0.20 = +0.0060); Actionability: 0.94 -> 0.95 (+0.01 x 0.15 = +0.0015); Total: +0.0075 |

**I4 fix outcome:** Single-word correction at line 277 eliminates the verifiable numerical contradiction introduced by the I3 sub-table addition. The text now states "5 specific upgrade recommendations" and the sub-table contains exactly 5 rows. No new defects introduced by the I4 fix. All I3 fixes remain intact (A-31 full citation, VS-001/VS-003 parenthetical, R-QE-001 through R-ADS-003 sub-table).

**All prior fixes remain in place:**

| Fix | Iteration | Status |
|-----|-----------|--------|
| A-31 full bibliographic citation (Bsharat, Myrzakhan, Shen, arXiv:2312.16171) | I3 | Intact |
| VS-001/VS-003 parenthetical disambiguation | I3 | Intact |
| R-QE-001 through R-ADS-003 compact sub-table (5 rows, 3 columns) | I3 | Intact |
| A-20 full bibliographic citation (Geng et al., AAAI 2026, arXiv:2502.15851) | I2 | Intact |
| A-15 full bibliographic citation (Ferraz et al., EMNLP 2024, arXiv:2410.06458) | I2 | Intact |
| Pre-Mortem/Risk Register scope distinction notes | I2 | Intact |
| Group 2 "5 framework-level + 27 agent-level" sourced | I2 | Intact |
| Step 5 connected to H-17 and FMEA RPN 150 | I2 | Intact |
| FMEA scale definitions (1/5/10 anchors for S/O/D) | I2 | Intact |
| Option scoring basis declared (0-3 per dimension, architect judgment) | I2 | Intact |
| Option 3 "HIGHEST" parenthetical clarification | I2 | Intact |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.96 | 0.1920 | All Nygard sections + L0/L1/L2 + 4 adversarial strategies + R-QE-001 through R-ADS-003 sub-table (5 rows) with corrected count; no substantive gaps remain |
| Internal Consistency | 0.20 | 0.95 | 0.1900 | I4 fixes the "6 vs. 5" count contradiction at line 277; all other consistency elements intact (Pre-Mortem/Risk Register scope distinction, option scoring basis, core logical chain) |
| Methodological Rigor | 0.20 | 0.95 | 0.1900 | FMEA scale definitions present; all 5 RPN values arithmetically verified; all 4 adversarial strategies rigorously applied; epistemological discipline maintained; I4 makes no changes to this dimension |
| Evidence Quality | 0.15 | 0.95 | 0.1425 | A-31 fully cited with arXiv:2312.16171 (I3); A-20/A-15 fully cited (I2); VS-001/VS-003 disambiguated (I3); all tier labels accurate; A-11 absent; AGREE-5 correctly labeled |
| Actionability | 0.15 | 0.95 | 0.1425 | "6 vs. 5" fix eliminates residual implementer ambiguity about missing entry; sub-table with 5 specific, implementable targets (ID, target file, description) now fully self-consistent; quality gate hook, 4-group sequencing, Phase 2 protocol all intact |
| Traceability | 0.10 | 0.95 | 0.0950 | All traceability chains intact; A-31 arXiv:2312.16171 traceable; VS-001/VS-003 disambiguated; 7 constraints with source citations; evidence tier table maps all 6 claims |
| **TOTAL** | **1.00** | | **0.9520** | |

**H-15 Arithmetic Verification:**
- Completeness: 0.96 x 0.20 = 0.1920
- Internal Consistency: 0.95 x 0.20 = 0.1900; running: 0.1920 + 0.1900 = 0.3820
- Methodological Rigor: 0.95 x 0.20 = 0.1900; running: 0.3820 + 0.1900 = 0.5720
- Evidence Quality: 0.95 x 0.15 = 0.1425; running: 0.5720 + 0.1425 = 0.7145
- Actionability: 0.95 x 0.15 = 0.1425; running: 0.7145 + 0.1425 = 0.8570
- Traceability: 0.95 x 0.10 = 0.0950; running: 0.8570 + 0.0950 = **0.9520** (confirmed)

**Distance from C4 threshold:** 0.9520 - 0.95 = **+0.0020** (above threshold)

---

## Detailed Dimension Analysis

### Completeness (0.96/1.00)

**Evidence:**

ADR-001 I4 addresses all mandatory requirements with depth:

- All five Nygard sections (Title, Status, Context, Decision, Consequences), extended with L0/L1/L2 levels
- Navigation table: all 13 sections with anchor links (H-23 compliant)
- Constraints table: C-001 through C-007 with source citations
- Forces: 4 tensions explicitly reasoned
- Options: 3 options each with steelman (S-003), pros, cons, fit with constraints, and score
- Decision with 4-point rationale and alignment table
- L1 Technical: diagnostic filter, 5-step upgrade procedure (with Step 5 quality gate hook), 4-group sequencing with counts and rationale, Phase 2 baseline protocol (4 steps), L2 token budget analysis
- L2 Architectural: evolution path (NPT progression diagram), systemic consequences (4 points), Pre-Mortem (5 failure modes with scope distinction note), FMEA (5 failure modes with full scale definitions), Inversion analysis
- Consequences: 5 positive, 5 negative, 3 neutral
- Consequences: Risks table: 6 entries with scope distinction note
- Compliance: PG-003 reversibility (5-component table), evidence tier labels (6 claims with tier and source), constraint propagation verification (GC-P4-1 through GC-P4-3)
- Related Decisions: 3 downstream ADRs with relationship descriptions
- References: 13 entries, all with type and relevance columns
- PS Integration with key findings for downstream handoff
- Self-Review Checklist: 17 checks with PASS status and notes

The R-QE-001 through R-ADS-003 sub-table contains 5 rows with ID, Target Rule File, and Description columns. Line 277 now states "5 specific upgrade recommendations" matching the sub-table count exactly.

**Gaps:**

No substantive completeness gaps remain. The 0.04 gap from 1.00 reflects that the document, while comprehensive, does not enumerate the 37 Group 3 SKILL.md targets or the 34+13 Group 4 pattern/template targets individually (these are deferred to TASK-010, TASK-013, TASK-014 respectively, which is a reasonable and documented design choice, not a completeness failure).

**Improvement Path:**

Completeness is not the binding constraint for quality gate passage. No improvement recommended on this dimension.

---

### Internal Consistency (0.95/1.00)

**Evidence:**

The I4 single-word fix resolves the isolated numerical contradiction introduced by I3:

- **Line 277 (I4 fix):** "TASK-012 identified **5** specific upgrade recommendations (R-QE-001 through R-ADS-003)." The numeral "5" matches the sub-table row count: R-QE-001, R-QE-002, R-ADS-001, R-ADS-002, R-ADS-003 = 5 rows. The code range "R-QE-001 through R-ADS-003" spans 5 identifiers. All three representations (numeral, code range, table) are now consistent.

All I2 consistency resolutions remain intact:
- **Pre-Mortem / Risk Register scope distinction:** Line 360 scope note (failure discovery methodology) and line 476 scope note (formal risk register) both present and differentiated.
- **Option scoring basis:** Line 194 paragraph with explicit 0-3 per dimension, summed and normalized to /10, labeled as architect judgment.
- **Core logical chain:** T1+T3 evidence -> NPT-014 underperforms -> PG-001 unconditional -> Phase 2 irrelevant -> universal policy. Stated consistently in L0 (lines 44-48), Context/Evidence Base (lines 88-99), Decision/Rationale (lines 212-218), Compliance (lines 454-462). No contradictions in this chain.

**Gaps:**

No remaining consistency gaps identified. The I4 fix eliminates the single verifiable contradiction from I3. Independent verification: line 277 numeral (5) = sub-table row count (5 rows counted manually) = code range span (R-QE-001, R-QE-002, R-ADS-001, R-ADS-002, R-ADS-003 = 5 identifiers). Three-way consistency confirmed.

**Score rationale for 0.95 vs. 0.96+:**

Uncertain scores are resolved downward per the leniency bias counteraction rule. The 0.05 gap from 1.00 acknowledges that the I3 regression was introduced by a fix (not original authorship error), and that the I4 fix is a targeted single-edit correction rather than a comprehensive revision. The document achieves near-full consistency; the 0.95 is appropriate and not lenient.

**Improvement Path:**

No improvement needed on this dimension to meet the quality gate.

---

### Methodological Rigor (0.95/1.00)

**Evidence:**

I4 makes no changes affecting this dimension. All I2 methodological resolutions remain intact and verified:

- **FMEA scale definitions (lines 374-374):** Full paragraph defining 1-anchor, 5-anchor, and 10-anchor for Severity, Occurrence, and Detection. All individual S/O/D values in the FMEA table can be independently audited against the defined scale.
- **FMEA arithmetic verified:** 4x6x3=72, 8x3x2=48, 5x5x4=100, 6x5x5=150, 7x2x2=28. All five RPNs confirmed correct by independent calculation.
- **Option 3 "HIGHEST" clarified (line 200):** "(zero-change avoidance, not positive Phase 2 support)" parenthetical prevents misreading that Option 3 has positive Phase 2 support value.
- **Option scoring basis declared (line 194):** "Scores reflect the architect's synthesis judgment across the three evaluation dimensions... each rated 0-3... summed and normalized to a /10 scale." Honest acknowledgment that scores are qualitative synthesis.
- **All 4 adversarial strategies rigorously applied:** S-003 (steelman per option, 3 steelman paragraphs), S-004 (Pre-Mortem with 5 failure modes and scope distinction), S-012 (FMEA with defined scale and 5 failure modes), S-013 (Inversion analysis with 5 specific consequences).
- **Epistemological discipline:** MANDATORY EPISTEMOLOGICAL BOUNDARY clearly stated (line 86); UNTESTED label applied to NPT-009 vs. positive framing comparison (line 461); T4 inferences labeled as inferences (lines 413, 356).
- **L2 token budget arithmetic verified:** 745/850 = 87.647%, within the 850-token ceiling.

**Gaps:**

No remaining methodological rigor gaps identified.

**Improvement Path:**

No improvement needed on this dimension.

---

### Evidence Quality (0.95/1.00)

**Evidence:**

All evidence quality gaps from I1 through I3 are resolved and unchanged in I4:

1. **A-31 full bibliographic citation (I3 fix, line 505):** "Bsharat, Myrzakhan, Shen. 'Principled Instructions Are All You Need for Questioning LLaMA-2, GPT-3.5/4.' [arXiv:2312.16171](https://arxiv.org/abs/2312.16171) (2023)." Full author list (3 authors), title, arXiv identifier with hyperlink, publication year. Paper is independently verifiable without accessing upstream barrier-1 survey files. Citation description adds substantive content: "affirmative directives showed 55% improvement and 66.7% correctness increase for GPT-4 vs. prohibitions" -- specific quantitative claims, not a placeholder.

2. **VS-001/VS-003 parenthetical disambiguation (I3 fix, line 507):** "(VS-001: 33-instance NEVER/MUST NOT/FORBIDDEN/DO NOT vendor self-practice catalog; VS-003: HARD tier vocabulary as structured negative vocabulary observation)" -- reader can distinguish VS-001 from VS-003 without consulting supplemental-vendor-evidence.md.

3. **A-20 full citation (I2 fix, line 503):** "Geng, Li, Mu, Han, Baldwin, Abend, Hovy, Frermann. 'Control Illusion: The Failure of Instruction Hierarchies in Large Language Models.' AAAI 2026 Main Technical Track. [arXiv:2502.15851](https://arxiv.org/abs/2502.15851)" -- full author list, title, venue, arXiv URL.

4. **A-15 full citation (I2 fix, line 504):** "Ferraz, Mehta, Lin, Chang, Oraby, Liu, Subramanian, Chung, Bansal, Peng. 'LLM Self-Correction with DeCRIM.' EMNLP 2024 Findings. [arXiv:2410.06458](https://arxiv.org/abs/2410.06458)" -- full author list, title, venue, arXiv URL.

5. **Evidence tier assignments:** T1 for peer-reviewed (A-20, A-15), T3 for preprint (A-31), T4 for observational/compiled (VS-001 through VS-004, TASK-012, barrier-4/synthesis.md), UNTESTED for Phase 2 framing comparison. All 6 claims in the Compliance evidence tier table carry explicit tier labels and source citations.

6. **A-11 absent:** Zero citation occurrences in evidence role. Only appears in constraint prohibition (lines 107, 541, 557).

7. **AGREE-5 correctly labeled:** Line 64 -- "internally generated, NOT externally validated" -- not cited as T1 or T3 anywhere.

**Gaps:**

No remaining evidence quality gaps identified.

**Improvement Path:**

No improvement needed on this dimension.

---

### Actionability (0.95/1.00)

**Evidence:**

The I4 fix resolves the residual actionability impediment from I3:

1. **"6 vs. 5" fix (I4):** Line 277 now states "5 specific upgrade recommendations." The sub-table contains exactly 5 rows. An implementer executing Group 1 encounters a consistent count: the text says 5, the table has 5 rows. No ambiguity about whether a missing 6th recommendation exists. The implementer can proceed directly to executing the 5 specific targets without searching for a phantom entry.

2. **R-QE-001 through R-ADS-003 sub-table (I3, lines 279-285):** A 3-column table (ID, Target Rule File, Description) enumerates: R-QE-001 (quality-enforcement.md, consequence to rank=3 L2-REINJECT marker), R-QE-002 (quality-enforcement.md, consequence requirement in L2 marker guidance), R-ADS-001 (agent-development-standards.md, reclassify CP-01/CP-04 from HARD to MEDIUM), R-ADS-002 (agent-development-standards.md, constitutional triplet prohibition to L2-REINJECT rank=5), R-ADS-003 (agent-development-standards.md, consequence + alternative to hexagonal dependency rule). An implementer knows exactly which files to open and what change to make for each of the 5 recommendations.

3. **Step 5 quality gate hook (I2, line 269):** "This validation step MUST be integrated into the H-17 quality scoring process. The NPT-014 diagnostic filter serves as the validation predicate." Closes the implementation loop.

4. **Diagnostic filter (lines 237-242):** Binary, implementable. A constraint is NPT-014 if it lacks ALL THREE of: (1) consequence, (2) scope, (3) positive alternative. Clear test.

5. **4-group sequencing (lines 275-302):** Clear order with rationale and counts for all groups. Groups 3 and 4 explicitly identified as parallelizable after Group 1 completes.

6. **Phase 2 baseline preservation protocol (lines 307-311):** 4 numbered steps with specific actions (branch isolation, commit-hash documentation).

7. **NPT-014 upgrade procedure (steps 1-5, lines 248-269):** 5-step procedure with specific sub-actions at each step.

**Gaps:**

No remaining actionability gaps identified.

**Improvement Path:**

No improvement needed on this dimension.

---

### Traceability (0.95/1.00)

**Evidence:**

All traceability chains from I2 and I3 remain intact and unchanged in I4:

1. **A-31 traceability (I3 fix):** arXiv:2312.16171 provides a stable, publicly accessible identifier. Independent verifier can retrieve the paper without accessing upstream barrier-1 files.

2. **VS-001/VS-003 disambiguation (I3 fix):** The parenthetical in References entry #5 enables a reader to trace which vendor self-practice observation corresponds to which ID without consulting supplemental-vendor-evidence.md.

3. **Primary traceability chains (all intact):**
   - PG-001 -> barrier-2/synthesis.md ST-4 (T1+T3 unconditional)
   - 22 NPT-014 instances -> TASK-012 (T4 compiled)
   - 130 total recommendations -> barrier-4/synthesis.md L0
   - 5-domain universal NPT-014 presence -> barrier-4/synthesis.md Themes 1 and 2
   - Phase 2 unconditional exception -> barrier-4/synthesis.md Section 3 (quoted)
   - "5 framework-level" -> barrier-4/synthesis.md L1 Recommendation Counts table
   - Option scoring -> labeled as architect judgment (transparent about evaluative nature)

4. **Constraint table (C-001 through C-007):** All 7 constraints have source citations.

5. **Evidence tier table (Compliance section):** All 6 claims mapped to tiers and sources.

6. **References table (13 entries):** All entries include type (T1/T3/T4) and relevance columns. Phase 4 analyses include quality scores (0.950 through 0.957 PASS).

**Gaps:**

No remaining traceability gaps identified.

**Improvement Path:**

No improvement needed on this dimension.

---

## Improvement Recommendations (Priority Ordered)

No improvements required. The composite score of 0.9520 exceeds the C4 threshold of 0.95 by 0.0020. All six dimensions meet or exceed the 0.95 level. All gate checks pass.

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| -- | All | 0.95+ | -- | Quality gate passed. No improvements required for acceptance. |

**Score trajectory summary:**

| Iteration | Score | Delta | Cause |
|-----------|-------|-------|-------|
| I1 | 0.9185 | baseline | Initial ADR -- 6 gaps identified |
| I2 | 0.9455 | +0.0270 | 4 targeted fixes (FMEA scale, citations, scope distinction, scoring basis) |
| I3 | 0.9445 | -0.0010 | Regression: "6 vs. 5" contradiction introduced by sub-table fix |
| I4 | 0.9520 | +0.0075 | Single-edit fix: "6" -> "5" at line 277; Internal Consistency 0.92->0.95, Actionability 0.94->0.95 |

---

## ADR-Specific Gate Check Summary

| Gate | Check | Result | Notes |
|------|-------|--------|-------|
| GC-ADR-1 | Nygard format complete | PASS | Title, Status, Context, Decision, Consequences all present; extended with L0/L1/L2 |
| GC-ADR-2 | Evidence tier labels on all claims | PASS | A-31 fully cited with arXiv:2312.16171; A-20/A-15 fully cited with arXiv URLs; VS-001/VS-003 disambiguated; all 6 claims in Compliance table carry tier labels |
| GC-ADR-3 | PG-003 reversibility documented | PASS | Full 5-component table; HIGH overall; null-framing contingency analyzed |
| GC-ADR-4 | Phase 2 dependency handled | PASS | Unconditional exception stated; sourced to barrier-4/synthesis.md Section 3 |
| GC-ADR-5 | No false validation claims | PASS | MANDATORY EPISTEMOLOGICAL BOUNDARY enforced; UNTESTED labels applied; A-11 absent |

---

## Leniency Bias Check

- [x] Each dimension scored independently before composite computed
- [x] Evidence documented for each score with specific line numbers and content cited
- [x] Uncertain scores resolved downward: Completeness held at 0.96 (not 0.97+) because Groups 3/4 individual targets are not enumerated in the ADR body (documented design choice, but reflects genuine scope limitation)
- [x] Internal Consistency scored at 0.95 (not 0.97) because the I3 regression was introduced mid-iteration by a fix, even though I4 resolves it cleanly; 0.95 reflects the dimension's current clean state with appropriate caution about the recent revision history
- [x] No dimension above 0.96 -- Completeness at 0.96, all others at 0.95
- [x] C4 threshold (0.95) held firm -- composite of 0.9520 is correctly above threshold by exactly 0.0020
- [x] Score trajectory checked for consistency: I4 (+0.0075) matches the estimated impact from I3 (+0.0060 from Internal Consistency + 0.0015 from Actionability = +0.0075) -- confirmed
- [x] FMEA arithmetic independently verified: 4x6x3=72, 8x3x2=48, 5x5x4=100, 6x5x5=150, 7x2x2=28 -- all correct
- [x] L2 token budget arithmetic independently verified: 745/850 = 87.647% -- within 850-token ceiling
- [x] A-11 absence confirmed: zero occurrences in evidence role; only appears in constraint prohibition (lines 107, 541, 557)
- [x] AGREE-5 over-citation checked: correctly labeled at line 64; not cited as T1 or T3 anywhere
- [x] "5 vs. 5" consistency verified: line 277 text says "5"; sub-table rows counted = 5 (R-QE-001, R-QE-002, R-ADS-001, R-ADS-002, R-ADS-003); code range "R-QE-001 through R-ADS-003" spans exactly 5 identifiers -- three-way consistency confirmed
- [x] No leniency applied to PASS verdict: 0.9520 genuinely exceeds 0.95 threshold; the margin (+0.0020) is real and traceable to specific dimension scores

---

## Session Context (Handoff Schema)

```yaml
verdict: PASS
composite_score: 0.9520
threshold: 0.95
standard_threshold: 0.92
weakest_dimension: Completeness
weakest_score: 0.96
critical_findings_count: 0
iteration: 4
prior_score: 0.9445
score_delta: +0.0075
distance_from_threshold: +0.0020
score_trajectory: "I1: 0.9185 -> I2: 0.9455 (+0.0270) -> I3: 0.9445 (-0.0010) -> I4: 0.9520 (+0.0075)"
top_gap_dimensions:
  - "Completeness (0.96): Groups 3/4 individual targets not enumerated in ADR body -- documented design choice deferred to TASK-010/TASK-013/TASK-014; not a blocking gap"
improvement_recommendations: []
gate_checks_passed: [GC-ADR-1, GC-ADR-2, GC-ADR-3, GC-ADR-4, GC-ADR-5]
gate_checks_with_minor_gap: []
blocking_findings: none
arithmetic_verified: true
i4_fixes_applied: ["line_277_count_corrected_6_to_5"]
i4_fix_defects: none
i3_regression_resolved: true
all_prior_fixes_intact: true
```

---

*Scored by: adv-scorer*
*Strategy: S-014 (LLM-as-Judge, 6-dimension weighted composite)*
*Criticality: C4 (threshold 0.95)*
*SSOT: `.context/rules/quality-enforcement.md`*
*Workflow: neg-prompting-20260227-001*
*Task: TASK-016 (phase-5 ADR scoring, I4)*
*Created: 2026-02-28*
